Corona Virus Infection
📧 Sign up to get email alerts when something new happens for Corona Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 [Phase 3]
A Phase 3 clinical study evaluating the effect of CimetrA in patients diagnosed with COVID-19 is listed, with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia [Phase 2]
Phase 2 trial update on convalescent plasma for treating COVID-19 pneumonia; study completed and results posted.
-
CLINICAL_TRIALS research · 2022-02-28Clinical Trial Update: Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS [NA]
A completed clinical trial comparing early prone positioning with high-flow nasal cannula versus high-flow nasal cannula alone in COVID-19–r…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Efficacy of Iodine Complex Against COVID-19 Patients [Phase 1, Phase 2]
Trial update indicates ongoing Phase 1/2 evaluation of an iodine complex for COVID-19; status not yet determined.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Pre-exposure Prophylaxis for SARS-Coronavirus-2 [Phase 3]
Phase 3 trial update on pre-exposure prophylaxis for SARS-CoV-2 completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia [Phase 2, Phase 3]
A clinical trial update reports on the efficacy of nafamostat mesylate for COVID-19 pneumonia in Phase 2 and Phase 3; no current status avai…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial [Phase 2]
A Phase 2 clinical trial update for baricitinib in COVID-19 pneumonia is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 [Phase 2]
Phase 2 trial evaluating enhanced platelet inhibition in critically ill COVID-19 patients has completed.